adoptive autologous iNKT cells

· Beijing YouAn Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for adoptive autologous iNKT cells, covering 2024-01-16 to 2024-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy [Phase 2]

See pricing